Has Monkeypox Been Genetically Manipulated?

Two Studies now suggest the circulating Monkeypox Virus has been manipulated in a Biolab

 THE EXPOSÉ 

Recently we revealed how a study published by Portugal’s Institute for Health had found abnormal mutations among the alleged circulating monkeypox virus suggesting it had been manipulated and edited in a biolab. Now a second study has been published adding weight to this theory.

Monkeypox illness usually begins with a fever before a rash develops one to five days later, often beginning on the face then spreading to other parts of the body. The rash changes and goes through different stages before finally forming a scab which later falls off. An individual is contagious until all the scabs have fallen off and there is intact skin underneath.

The disease has always been extremely rare and was first identified in humans in 1970 in the Democratic Republic of the Congo in a 9-year-old boy. Since then, human cases of monkeypox have been reported in 11 African countries. It wasn’t until 2003 that the first monkeypox outbreak outside of Africa was recorded, and this was in the United States, and it has never been recorded in multiple countries at the same time.

Until now.

A new study published by Portugal’s National Institute of Health has uncovered evidence that the virus responsible for the Monkeypox outbreak allegedly sweeping across Europe, America and Australia, has been heavily manipulated in a lab by scientists, and further evidence suggests it has been released intentionally.

The study was published May 23rd 2022 and can be accessed in full here.

Richard Neher, a computational evolutionary biologist at the University of Basel has publicly claimed in the mainstream media that –

“Based on normal evolutionary timelines, scientists would expect a virus like monkeypox to pick up that many mutations over perhaps 50 years, not four. That is somewhat remarkable.”

More...

Scientists Make A Shocking Monkeypox Discovery: “There Are Way More Mutations Than Expected”

Monkeypox continues to spread to more areas around the globe, but so far there is not the same sort of widespread alarm that we witnessed during the early stages of the COVID pandemic.  One of the big reasons for this is because global health authorities have been assuring us that there isn’t much of a risk to the general population.  More than a week ago, the World Health Organization boldly announced that there was no evidence that the monkeypox virus had mutated, and so everyone assumed that this outbreak would not become a global crisis.  Well, it turns out that the World Health Organization spoke way too soon.  Scientists are now telling us that there are lots and lots of mutations in the new strain that has been spreading like wildfire all over the planet.  In fact, it is being reported that “there are way more mutations than expected”…

DNA viruses, particularly those with relatively big genomes like poxviruses (the family that includes monkeypox), generally accrue mutations much more slowly than, say, an RNA virus like SARS-CoV-2, which causes Covid-19. That means that examining the sequences might be less fruitful in terms of tracking how the virus is spreading from person to person. There are fewer changes to the virus’ genome that might shine a light on transmission chains.

But as researchers around the world share sequences from the current outbreak, the genomes have revealed something odd: There are way more mutations than expected.

Most notably, there are a whole lot of mutations that appear across the new sequences. The genomes from the current outbreak share 40-some mutations with each other that distinguish them from their closest relatives, which were from around 2018. (The exact number of mutations varies depending on how certain changes are counted.)

Of course monkeypox has been spreading in central Africa for quite some time now.

So far this year, there have been 1,284 confirmed cases in the Democratic Republic of Congo alone, and 58 of those cases have died…

The World Health Organization is now claiming that monkeypox has been “spreading undetected” outside of Africa for “some time” now, but they aren’t being any more specific than that.

In response to recent developments, the CDC has now decided to escalate the travel warning for this outbreak to “Alert Level 2”…

According to reports, an “Alert Level 2” has been issued advising travelers to “practice enhanced precautions.” This is similar to the travel recommendations that were issued at the start of the Wuhan coronavirus (Covid-19) plandemic, only to eventually become mandates.

The new advisory urges travelers to avoid people with “skin lesions” or “genital lesions,” as well as wild animals and small mammals such as rodents (rats and squirrels) and non-human primates (monkeys and apes).

As more cases are uncovered in a global monkeypox outbreak, biotech companies and health officials are looking to make PCR testing for the virus more widely available in the US.

Dozens of public health labs across the country now use a more generalized test for orthopoxvirus, a larger category that includes monkeypox, smallpox and other viruses. Two biotechnology companies, Roche and Abbott, have announced plans to roll out monkeypox PCR tests, although right now, their test kits are for research only.

Here we go again, eh?